Medicinal Genomics

Going forward, the company will focus on its wholly owned subsidiary Medicinal Genomics Corporation, which conducts cannabis genetics research.

The SBIR Phase 1 award will go toward developing a test using immuno-PCR technology to detect toxins in medical marijuana. 

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Courtagen Life Sciences today said that it has acquired Medicinal Genomics, a Marblehead, Mass.-based firm that has sequenced the genome of Cannabis sativa and Cannabis indica.

By Julia Karow
This article, originally published Jan. 17, has been updated with additional information from Courtagen.

Genetic cancer researcher Constance Griffin has passed away from pancreatic cancer.

Paired Ends

Premium

Kevin McKernan has founded Medicinal Genomics and is also now serving as its CEO. Most recently, he was the head of R&D for Ion Torrent at Life Technologies.

While gene therapies may have high price tags, they could be cheaper than the cost of managing disease, according to MIT's Technology Review.

Researchers are looking for markers that indicate which cancer patients may respond to immunotherapies, the Associated Press writes.

In Nature this week: paternal age associated with de novo mutations in children, and more.

Nature News writes that researchers are still wrangling over the role of the p-value.